Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.35 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20179968 | 1.00 | CHRM5 (0.50) | CHRM5CHRM3SMN1; SMN2SIGMAR1RAB9A | |
| SCHEMBL21946897 | 0.98 | CHRM5 (0.51) | CHRM5CHRM3SMN1; SMN2SIGMAR1RAB9A | |
| SCHEMBL22147374 | 0.90 | CHRM3 (0.42) | CHRM5CHRM3SMN1; SMN2SIGMAR1RAB9A | |
| SCHEMBL19450983 | 0.82 | CHRM5 (0.41) | CHRM5CHRM3SMN1; SMN2RAB9AMEN1 | |
| SCHEMBL8484657 | 0.81 | SIGMAR1 (0.47) | CHRM5CHRM3SIGMAR1ALDH1A1TSHR | |
| SCHEMBL2722240 | 0.81 | CHRM5 (0.41) | CHRM5CHRM3SMN1; SMN2SIGMAR1MEN1 | |
| Ethyl Piperazinoacetate SCHEMBL5699 | 0.79 | SIGMAR1 (0.49) | CHRM5CHRM3SIGMAR1MEN1KMT2A | |
| SCHEMBL18942447 | 0.78 | KDM4E (0.47) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| Ethyl Piperazinoacetate SCHEMBL17271810 | 0.77 | SIGMAR1 (0.47) | CHRM5CHRM3SMN1; SMN2SIGMAR1ALDH1A1 | |
| SCHEMBL8911402 | 0.77 | SIGMAR1 (0.47) | CHRM5CHRM3SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10556873-B2 | Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using | ILLINOIS INSTITUTE OF TECHNOLOGY (US) | 2020-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10556873-B2 | Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using | UACA, CLTC, CLTA | CHRM5 3801/4885CHRM3 3339/4885SMN1; SMN2 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.